Patents by Inventor Bo Young Park

Bo Young Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170322723
    Abstract: Method and apparatus for executing function on a plurality of items on list are provided, one of methods comprises, receiving a touch gesture in a first direction on a first item on a list, determining the first item to be an execution target of a preset function in response to the touch gesture in the first direction, receiving a touch gesture in a second direction on a second item, adding the second item as an execution target of the preset function in response to the touch gesture in the second direction, receiving a touch gesture in the first direction, which is successive to the touch gesture in the second direction, on the added second item and executing the preset function on the first item and the second item in response to the touch gesture in the first direction on the added second item.
    Type: Application
    Filed: May 8, 2017
    Publication date: November 9, 2017
    Applicant: SAMSUNG SDS CO., LTD.
    Inventors: You Jin JANG, Bo Young PARK, Jeong Eon JU, Ja Young YOUN
  • Patent number: 8974837
    Abstract: The present invention relates to a composition comprising an extract of Pseudolysimachion genus plant, and the catalpol derivatives isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Pseudolysimachion genus plant and the catalpol derivatives isolated therefrom shows potent suppressing effect on elevated IgE, IL-4 and IL-13 levels and eosinophilia in the plasma and BALF, and mucus overproduction in the lung tissues in an OVA-induced asthmatic mouse model. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.
    Type: Grant
    Filed: March 22, 2012
    Date of Patent: March 10, 2015
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Hyeong Kyu Lee, Sei Ryang Oh, Kyung Seop Ahn, Sang Ku Lee, Joong Ku Lee, Ok Kyoung Kwon, Doo Young Kim, Hyouk Joung, Gui Hua Quan, Mi Jin Kim, Bo Young Park
  • Patent number: 8455541
    Abstract: The present invention relates to a composition comprising an extract of Pseudolysimachion genus plant, and the catalpol derivatives isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Pseudolysimachion genus plant and the catalpol derivatives isolated therefrom shows potent suppressing effect on elevated IgE, IL-4 and IL-13 levels and eosinophilia in the plasma and BALF, and mucus overproduction in the lung tissues in an OVA-induced asthmatic mouse model. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.
    Type: Grant
    Filed: March 22, 2012
    Date of Patent: June 4, 2013
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Hyeong Kyu Lee, Sei Ryang Oh, Kyung Seop Ahn, Sang Ku Lee, Joong Ku Lee, Ok Kyoung Kwon, Doo Young Kim, Hyouk Joung, Gui Hua Quan, Mi Jin Kim, Bo Young Park
  • Publication number: 20120184499
    Abstract: The present invention relates to a composition comprising an extract of Pseudolysimachion genus plant, and the catalpol derivatives isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Pseudolysimachion genus plant and the catalpol derivatives isolated therefrom shows potent suppressing effect on elevated IgE, IL-4 and IL-13 levels and eosinophilia in the plasma and BALF, and mucus overproduction in the lung tissues in an OVA-induced asthmatic mouse model. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.
    Type: Application
    Filed: March 22, 2012
    Publication date: July 19, 2012
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Hyeong Kyu LEE, Sei Ryang-Oh, Kyung Seop AHN, Sang Ku LEE, Joong Ku LEE, Ok Kyoung KWON, Doo Young KIM, Hyouk JOUNG, Gui Hua QUAN, Mi Jin KIM, Bo Young PARK
  • Publication number: 20120183632
    Abstract: The present invention relates to a composition comprising an extract of Pseudolysimachion genus plant, and the catalpol derivatives isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Pseudolysimachion genus plant and the catalpol derivatives isolated therefrom shows potent suppressing effect on elevated IgE, IL-4 and IL-13 levels and eosinophilia in the plasma and BALF, and mucus overproduction in the lung tissues in an OVA-induced asthmatic mouse model. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.
    Type: Application
    Filed: March 22, 2012
    Publication date: July 19, 2012
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Hyeong Kyu LEE, Sei Ryang OH, Kyung Seop AHN, Sang Ku LEE, Joong Ku LEE, Ok Kyoung KWON, Doo Young KIM, Hyouk JOUNG, Gui Hua QUAN, Mi Jin KIM, Bo Young PARK
  • Patent number: 8168235
    Abstract: The present invention relates to a composition comprising an extract of Pseudolysimachion genus plant, and the catalpol derivatives isolated therefrom having anti-inflammatory, antiallergic and anti-asthmatic activity. The extract of Pseudolysimachion genus plant and the catalpol derivatives isolated therefrom shows potent suppressing effect on elevated IgE, IL-4 and IL-13 levels and eosinophilia in the plasma and BALF, and mucus overproduction in the lung tissues in an OVA-induced asthmatic mouse model. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.
    Type: Grant
    Filed: May 30, 2006
    Date of Patent: May 1, 2012
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Hyeong Kyu Lee, Sei Ryang Oh, Kyung Seop Ahn, Sang Ku Lee, Joong Ku Lee, Ok Kyoung Kwon, Doo Young Kim, Hyouk Joung, Gui Hua Quan, Mi Jin Kim, Bo Young Park
  • Patent number: 7763286
    Abstract: The present invention relates to a composition comprising an extract of Tiarella polyphylla, and tiarellic acid isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Tiarella polyphylla and the tiarellic acid isolated therefrom shows the inhibitory effect on the LTC4 release in vitro test and the suppressive effect on the IgE level and the cytokine (IL-4, IL-5 and IL-13) production, airway hyperresponsiveness, and leukocyte infiltration in OVA-induced asthmatic mice. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: July 27, 2010
    Assignee: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Hyeong Kyu Lee, Sei Ryang Oh, Kyung Seop Ahn, Joong Ku Lee, Sang Ku Lee, Jung Hee Kim, Doo Young Kim, Gui Hua Quan, Ok Kyoung Kwon, Eun Ah Kim, Soon Ja Choi, Guang Hai Shen, Mi Jin Kim, Bo Young Park, Byung Sun Min, Gyoon Hee Han, Hea Young Park, Gun Cheol Kim, Joo Heon Kim, So Young Kim
  • Publication number: 20090324750
    Abstract: The present invention relates to a composition comprising an extract of Pseudolysimachion genus plant, and the catalpol derivatives isolated therefrom having anti-inflammatory, antiallergic and anti-asthmatic activity. The extract of Pseudolysimachion genus plant and the catalpol derivatives isolated therefrom shows potent suppressing effect on elevated IgE, IL-4 and IL-13 levels and cosinophilia in the plasma and BALF, and mucus overproduction in the lung tissues in an OVA-induced asthmatic mouse model. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.
    Type: Application
    Filed: May 30, 2006
    Publication date: December 31, 2009
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Hyeong Kyu Lee, Sei Ryang Oh, Kyung Seop Ahn, Sang Ku Lee, Joong Ku Lee, Ok Kyoung Kwon, Doo Young Kim, Hyouk Joung, Gui Hua Quan, Mi Jin Kim, Bo Young Park
  • Publication number: 20090148542
    Abstract: The present invention relates to a composition comprising an extract of Tiarella polyphylla, and tiarellic acid isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Tiarella polyphylla and the tiarellic acid isolated therefrom shows the inhibitory effect on the LTC4 release in vitro test and the suppressive effect on the IgE level and the cytokine (IL-4, IL-5 and IL-13) production, airway hyperresponsiveness, and leukocyte infiltration in OVA-induced asthmatic mice. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.
    Type: Application
    Filed: July 18, 2006
    Publication date: June 11, 2009
    Applicant: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Hyeong Kyu Lee, Sei Ryang Oh, Kyung Seop Ahn, Joong Ku Lee, Sang Ku Lee, Jung Hee Kim, Doo Young Kim, Gui Hua Quan, Ok Kyoung Kwon, Eun Ah Kim, Soon Ja Choi, Guang Hai Shen, Mi Jin Kim, Bo Young Park, Byung Sun Min, Gyoon Hee Han, Hea Young Park, Gun Cheol Kim, Joo Heon Kim, So Young Kim
  • Patent number: D895499
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: September 8, 2020
    Assignee: Hyundai Mobis Co., Ltd.
    Inventors: Bo Young Park, Hyung Soo Kim, Jin Yung Bae, Min Hee Kim